Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer - Related Studies

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00080080. Last updated on June 7, 2007. Information provided by Point Therapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		talabostat (PT-100) tablets
		Docetaxel

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Point Therapeutics